What are the etiology and signs of pre-eclampsia and eclampsia in pregnant women, particularly those with a history of hypertension, obesity, or previous pregnancy complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etiology and Signs of Pre-eclampsia/Eclampsia

Etiology

Pre-eclampsia results from abnormal placentation leading to placental hypoxia, which triggers release of anti-angiogenic factors (particularly sFlt-1 and soluble endoglin) into maternal circulation, causing widespread endothelial dysfunction and multi-organ involvement. 1, 2

Primary Pathophysiologic Mechanisms

  • Defective placentation: Incomplete transformation of maternal spiral arteries occurs due to shallow cytotrophoblast invasion, resulting in high-resistance uteroplacental circulation and reduced placental perfusion 1, 2

  • Angiogenic imbalance: The hypoxic placenta releases excessive soluble fms-like tyrosine kinase-1 (sFlt-1), which acts as a decoy receptor antagonizing vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), leading to deficiency of these pro-angiogenic factors 2, 3

  • Systemic endothelial dysfunction: The angiogenic imbalance causes widespread endothelial dysfunction affecting kidneys (glomerular endotheliosis), liver (hepatic edema and hemorrhage), brain (cerebral edema), and vascular system 1, 2

  • Autoimmune activation: Circulating AT1 receptor autoantibodies are present in >95% of women with pre-eclampsia, inducing vasoconstriction, hypertension, and increased coagulation 2

Risk Factors

  • Obstetric factors: First pregnancy, multiple gestation, hydatidiform mole, history of pre-eclampsia in previous pregnancy (25% recurrence risk in women with chronic hypertension) 1

  • Medical comorbidities: Pre-existing chronic hypertension, diabetes mellitus, chronic kidney disease, autoimmune disorders (particularly antiphospholipid syndrome), obesity (BMI >35 kg/m²) 1

  • Demographic factors: Maternal age >40 years, pregnancy interval >10 years, family history of pre-eclampsia (relative risk 2.9) 1, 2

Signs and Symptoms

Diagnostic Criteria

Pre-eclampsia is defined as new-onset hypertension (BP ≥140/90 mmHg) developing after 20 weeks gestation accompanied by either proteinuria (≥0.3 g/24 hours) or evidence of maternal organ dysfunction. 1

Clinical Manifestations by Severity

Mild to Moderate Pre-eclampsia:

  • Blood pressure 140-159/90-109 mmHg measured on two occasions at least 4 hours apart 1
  • Proteinuria ≥0.3 g/24 hours or protein:creatinine ratio ≥30 mg/mmol 1
  • Edema (present in up to 60% but no longer diagnostic criterion) 1

Severe Pre-eclampsia Features:

  • Cardiovascular: Severe hypertension (BP ≥160/110 mmHg) 1

  • Hepatic involvement: Right upper quadrant or epigastric pain due to liver capsule distension from edema and subcapsular hemorrhage; elevated liver transaminases (AST/ALT >2x upper limit of normal) 1, 4

  • Neurological manifestations: Severe persistent headache unresponsive to analgesics; visual disturbances including scotomata, photophobia, or cortical blindness; hyperreflexia with sustained clonus (≥3 beats) 1, 4

  • Renal dysfunction: Serum creatinine >1.1 mg/dL or doubling of baseline creatinine; oliguria (<500 mL/24 hours) 1, 3

  • Hematologic abnormalities: Thrombocytopenia (platelet count <100,000/μL); microangiopathic hemolysis with elevated LDH 1

  • Pulmonary edema: Dyspnea, oxygen desaturation, rales on auscultation 1

HELLP Syndrome

HELLP syndrome represents the severe end of the pre-eclampsia spectrum, characterized by hemolysis, elevated liver enzymes (AST/ALT >2x normal), and low platelets (<100,000/μL), requiring immediate treatment and delivery. 1

Eclampsia

Eclampsia is defined as new-onset generalized tonic-clonic seizures in a woman with pre-eclampsia that cannot be attributed to other causes, representing a life-threatening emergency. 1, 5

  • Seizures can occur antepartum (53%), intrapartum (19%), or postpartum (28%) 5
  • May occur without preceding severe features or warning symptoms in up to 20% of cases 4
  • Associated findings include loss of consciousness, postictal confusion, aspiration risk 5
  • Occipital lobe involvement may cause cortical blindness 1, 4

Fetal Manifestations

  • Intrauterine growth restriction due to placental insufficiency 1
  • Oligohydramnios from reduced placental perfusion 1
  • Abnormal fetal heart rate patterns indicating fetal compromise 4
  • Increased risk of preterm birth (pre-eclampsia accounts for 25% of infants with very low birth weight <1500 g) 1

Physical Examination Findings

  • Sustained blood pressure elevation on repeated measurements 1
  • Brisk deep tendon reflexes with clonus (≥3 beats at ankle) 1, 4
  • Right upper quadrant tenderness on palpation 1
  • Pulmonary rales if pulmonary edema present 4
  • Altered mental status or visual field defects in severe cases 1, 4

Laboratory Abnormalities

  • Proteinuria: spot urine protein:creatinine ratio ≥30 mg/mmol or 24-hour urine protein ≥300 mg 1
  • Elevated serum creatinine >1.1 mg/dL 1
  • Elevated liver transaminases (AST/ALT >2x normal) 1
  • Thrombocytopenia (<100,000/μL) 1
  • Elevated serum uric acid (though not diagnostic, correlates with worse outcomes) 1
  • Elevated LDH indicating hemolysis 1
  • Decreased haptoglobin if hemolysis present 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Eclampsia and PRES: Clinical Manifestations and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.